|
 |
|
|||||||
|
|||||||||
Diabetes 54:1238-1244, 2005
© 2005 by the American Diabetes Association, Inc.
Brief Genetics Report |
Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes
The DCCT/EDIC Genetics Study
1 Department of Medicine, University Health Network, University of Toronto, Toronto, Canada
2 Program in Genetics and Genomic Biology, Hospital for Sick Children, Toronto, Canada
3 Department of Public Health Sciences, University of Toronto, Toronto, Canada
4 Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Prosserman Center for Health Research, University of Toronto, Toronto, Canada
5 Leadership Sinai Centre for Diabetes, Department of Medicine, Mount Sinai Hospital, Toronto, Canada
The development and progression of microvascular complications have been extensively documented in a cohort of type 1 diabetic subjects enrolled in the Diabetes Control and Complications Trial (DCCT) and followed in the Epidemiology of Diabetes Interventions and Complications (EDIC) study. We describe the association of genetic variation in the ACE gene in 1,365 DCCT/EDIC subjects with incident persistent microalbuminuria (n = 312) and severe nephropathy (n = 115). We studied three markers (rs1800764, insertion/deletion, and rs9896208) in the ACE gene that allowed us to capture genetic variation in the common haplotypes occurring at frequencies of >5% in Caucasians. Compared with the more frequent genotype (D/I) for the insertion/deletion polymorphism, in multivariate models, the I/I genotype conferred a lower risk for persistent microalbuminuria (hazard ratio [HR] 0.62 [95% CI 0.43–0.89], P = 0.009) and severe nephropathy (0.56 [0.32–0.96], P = 0.033). Variation at the two other markers, rs1800764 and rs9896208, were also associated with these renal outcomes. In addition, homozygosity for the common haplotype TIC (which corresponded to the T, insertion, and C alleles at the three markers, rs1800764, insertion/deletion, and rs9896208, respectively) versus the CDT/TIC haplotype pair was associated with lower risk for development of persistent microalbuminuria (HR 0.49 [0.32–0.75], P = 0.0009) and severe nephropathy (0.41 [0.22–0.78], P = 0.006). Our findings in the DCCT/EDIC cohort provide strong evidence that genetic variation at the ACE gene is associated with the development of nephropathy in patients with type 1 diabetes.
Address correspondence and reprint requests to Andrew P. Boright, MD, PhD, Department of Medicine, Division of Endocrinology, University Health Network, 200 Elizabeth St., Toronto, Ontario, Canada M5G 2C4. E-mail: andy{at}genet.sickkids.on.ca
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  V.-P. Makinen, C. Forsblom, L. M. Thorn, J. Waden, D. Gordin, O. Heikkila, K. Hietala, L. Kyllonen, J. Kyto, M. Rosengard-Barlund, et al. Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes Diabetes, September 1, 2008; 57(9): 2480 - 2487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Al-Kateb, A. P. Boright, L. Mirea, X. Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, M. Liu, J. M. Bucksa, V. L. Arends, et al. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study Diabetes, January 1, 2008; 57(1): 218 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden Genetic Factors in Diabetic Nephropathy Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tarnow, P.-H. Groop, S. Hadjadj, G. Kazeem, F. Cambien, M. Marre, C. Forsblom, H.-H. Parving, D. Tregouet, A. Thevard, et al. European rational approach for the genetics of diabetic complications EURAGEDIC: patient populations and strategy Nephrol. Dial. Transplant., August 17, 2007; (2007) gfm501v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rao, J. Wessel, G. Wen, L. Zhang, B. K. Rana, B. P. Kennedy, T. A. Greenwood, R. M. Salem, Y. Chen, S. Khandrika, et al. Renal Albumin Excretion: Twin Studies Identify Influences of Heredity, Environment, and Adrenergic Pathway Polymorphism Hypertension, May 1, 2007; 49(5): 1015 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hadjadj, L. Tarnow, C. Forsblom, G. Kazeem, M. Marre, P.-H. Groop, H.-H. Parving, F. Cambien, D. A. Tregouet, I. G. Gut, et al. Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1284 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kretowski, K. McFann, J. E. Hokanson, D. Maahs, G. Kinney, J. K. Snell-Bergeon, R. P. Wadwa, R. H. Eckel, L. Ogden, S. Garg, et al. Polymorphisms of the Renin-Angiotensin System Genes Predict Progression of Subclinical Coronary Atherosclerosis Diabetes, March 1, 2007; 56(3): 863 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto Type 1 diabetes and coronary artery disease. Diabetes Care, November 1, 2006; 29(11): 2528 - 2538. [Full Text] [PDF]
|
|
|
|
 |
|
 F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman ACE Polymorphisms Circ. Res., May 12, 2006; 98(9): 1123 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P.A. Ebert, U. Lendeckel, S. Westphal, J. Dierkes, J. Glas, C. Folwaczny, A. Roessner, M. Stolte, P. Malfertheiner, and C. Rocken The Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism Is Linked to Early Gastric Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2987 - 2989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Weekers, B. Bouhanick, S. Hadjadj, Y. Gallois, R. Roussel, F. Pean, A. Ankotche, G. Chatellier, F. Alhenc-Gelas, P. J. Lefebvre, et al. Modulation of the Renal Response to ACE Inhibition by ACE Insertion/Deletion Polymorphism During Hyperglycemia in Normotensive, Normoalbuminuric Type 1 Diabetic Patients Diabetes, October 1, 2005; 54(10): 2961 - 2967. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |